Chemoinformaics analysis of 3-O-vanillyceanothic acid
| Molecular Weight | 636.826 | nRot | 6 |
| Heavy Atom Molecular Weight | 584.41 | nRig | 34 |
| Exact Molecular Weight | 636.366 | nRing | 6 |
| Solubility: LogS | -3.516 | nHRing | 0 |
| Solubility: LogP | 5.89 | No. of Aliphatic Rings | 5 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 98 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 38 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 104.549 |
| nHD | 3 | BPOL | 58.2428 |
| QED | 0.215 |
| Synth | 5.08 |
| Natural Product Likeliness | 2.363 |
| NR-PPAR-gamma | 0.944 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0 |
| HIA | 0.049 |
| CACO-2 | -5.523 |
| MDCK | 0.0000166 |
| BBB | 0.264 |
| PPB | 0.99417 |
| VDSS | 0.379 |
| FU | 0.0120637 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.839 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.802 |
| CYP2c9-inh | 0.109 |
| CYP2c9-sub | 0.81 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.17 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.095 |
| CL | 2.569 |
| T12 | 0.065 |
| hERG | 0.004 |
| Ames | 0.004 |
| ROA | 0.35 |
| SkinSen | 0.009 |
| Carcinogencity | 0.009 |
| EI | 0.039 |
| Respiratory | 0.805 |
| NR-Aromatase | 0.851 |
| Antiviral | Yes |
| Prediction | 0.889528 |